Physician profile
Jonathan L Skinner
NPI 1730184912
$7,068.74
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $6,479 · 2021: $64.99 · 2022: $123 · 2023: $81.63 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $3,280.00 | 2020 | |
| Intuitive Surgical, INC. | $3,275.91 | 2020-2024 | |
| Tela Bio, INC. | $175.16 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $111.28 | 2019 | |
| Merck Sharp & Dohme LLC | $56.03 | 2019-2020 | |
| Stimwave Technologies Incorporated | $32.81 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $29.69 | 2022-2023 | Seglentis |
| Depuy Synthes Sales INC. | $21.11 | 2021 | |
| Allergan, INC. | $19.05 | 2019 | |
| Organogenesis INC. | $18.86 | 2019 | |
| Portola Pharmaceuticals, LLC | $17.48 | 2020 | |
| Z-Medica, LLC | $17.09 | 2019 | |
| Braintree Laboratories, INC. | $14.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Skinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.